CVRx, Inc. - Common Stock (CVRX)

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CVRx, Inc. (“CVRx” or “the Company”) (NASDAQ: CVRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

A securities fraud class action lawsuit has been filed against CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX) on behalf of investors who purchased or otherwise acquired the Company's securities between July 25, 2023 and August 6, 2026, inclusive. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced the filing. The CVRx, Inc. case, Oklahoma Police Pension and Retirement System v. CVRx, Inc. et al., was filed on November 9, 2026 in the U.S. District Court District of Minnesota (Case No. 0:26-cv-04746). CVRx, Inc. investors have until January 8, 2027 to file a lead plaintiff motion.

CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX) is the subject of a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired the Company's securities from July 25, 2023 through August 6, 2026, inclusive. The Law Offices of Howard G. Smith today reported the lawsuit, Oklahoma Police Pension and Retirement System v. CVRx, Inc. et al., which was filed on November 9, 2026 in the U.S. District Court District of Minnesota (Case No. 0:26-cv-04746). The deadline for CVRx, Inc. investors to file a lead plaintiff motion is January 8, 2027.

NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) --

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of CVRx, Inc. (NASDAQ: CVRX) between July 25, 2023 and August 6, 2026, inclusive (the “Class Period”). CVRx is a commercial-stage medical device company.

A securities class action lawsuit has been filed against CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX) on behalf of investors who purchased or otherwise acquired CVRx, Inc. securities from July 25, 2023 to August 6, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Oklahoma Police Pension and Retirement System v. CVRx, Inc. et al., filed on November 9, 2026 in the U.S. District Court District of Minnesota (Case No. 0:26-cv-04746). Lead plaintiff motions in the CVRx, Inc. case are due by January 8, 2027.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) securities between July 25, 2023 and August 6, 2026, inclusive (“the Class Period”). If you suffered a loss on your CVRx investments, you have until January 8, 2027 to request lead plaintiff appointment.

Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons who purchased or otherwise acquired CVRx, Inc. (NASDAQ: CVRX) common stock between July 25, 2023 and August 6, 2026, inclusive (the “Class Period”). CVRx is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular disease.

NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The Law Offices of Frank R. Cruz announces an investigation of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) on behalf of investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) investors concerning the Company’s possible violations of federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) investors concerning the Company’s possible violations of the federal securities laws.

The Law Offices of Frank R. Cruz continues its investigation of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) on behalf of investors concerning the Company’s possible violations of federal securities laws.

Law Offices of Howard G. Smith continues its investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) investors concerning the Company’s possible violations of federal securities laws.

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Law Offices of Howard G. Smith announces an investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) on behalf of investors concerning the Company’s possible violations of federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) investors concerning the Company’s possible violations of the federal securities laws.

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The law firm of Kirby McInerney LLP continues its investigation on behalf of CVRx Inc. (“CVRx” or the “Company”) (NASDAQ:CVRX) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In CVRx (CVRX) To Contact Him Directly To Discuss Their Options